Resilient and Accelerated Scale-Up of Subcutaneously Administered Depot–Medroxyprogesterone Acetate in Nigeria (RASuDiN): A Mid-Line Study in COVID-19 Era
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.